By Benjamin Chiou
Date: Wednesday 30 Apr 2025
(Sharecast News) - PureTech Health impressed the market with its annual results for 2024, as the company maintained a strong cash position while hitting a number of key clinical and regulatory milestones during the year.
By Josh White
Date: Monday 16 Dec 2024
(Sharecast News) - London stocks ended lower on Monday as investors adopted a cautious stance ahead of a week filled with major central bank policy decisions.
By Benjamin Chiou
Date: Monday 16 Dec 2024
(Sharecast News) - Clinical-stage biotech group Puretech Health has announced promising results from the trial of its lung disease treatment deupirfenidone, which the lead investigator hailed as "extremely exciting".
Currency | UK Pounds |
Share Price | 136.20p |
Change Today | -0.40p |
% Change | -0.29 % |
52 Week High | 237.50 |
52 Week Low | 103.00 |
Volume | 430,681 |
Shares Issued | 240.19m |
Market Cap | £327.14m |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Strong Buy | 2 |
Buy | 0 |
Neutral | 0 |
Sell | 0 |
Strong Sell | 0 |
Total | 2 |
No dividends found |
Time | Volume / Share Price |
16:35 | 92,225 @ 136.20p |
16:35 | 644 @ 136.20p |
16:35 | 1,478 @ 136.20p |
16:35 | 314 @ 136.20p |
16:35 | 315 @ 136.20p |
Chair | Raju Kucherlapati |
CEO | Bharatt Chowrira |
You are here: research